Toddler declared brain dead after asthma attack granted just one more week on life support as parents insist ‘he’s … – Daily Mail


Daily Mail

Toddler declared brain dead after asthma attack granted just one more week on life support as parents insist 'he's
Daily Mail
A judge has granted a one-week extension for a toddler to be kept on life support to give an appeals court time to weigh in. Two-year-old Israel Stinson was admitted to hospital at the beginning of April after suffering a severe asthma attack. After
?California toddler can stay on life support 1 more week, judge ruleswreg.com
Family of boy declared brain-dead receives extension to file an appeal to keep him on life supportKTVU San Francisco
Judge rejects parents' plea to keep brain-dead son on life supportThe News Tribune
ABC News –Sacramento Bee
all 55 news articles »

View full post on asthma – Google News

AB Science Announces That FDA Authorization (IND) Has Been Granted for the … – EON: Enhanced Online News (press release)

AB Science Announces That FDA Authorization (IND) Has Been Granted for the
EON: Enhanced Online News (press release)
For the record, severe persistent asthma uncontrolled with oral corticosteroids is a disease that has no registered treatment and all the immunosuppressant and biologic drugs tested to date have failed. Masitinib is therefore the only drug candidate in

and more »

View full post on asthma – Google News

AB Science Announces That FDA Authorization (IND) Has Been Granted for the … – MarketWatch (press release)

AB Science Announces That FDA Authorization (IND) Has Been Granted for the
MarketWatch (press release)
For the record, severe persistent asthma uncontrolled with oral corticosteroids is a disease that has no registered treatment and all the immunosuppressant and biologic drugs tested to date have failed. Masitinib is therefore the only drug candidate in

and more »

View full post on asthma – Google News

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, “5-Lipoxygenase Activating Protein (FLAP) Inhibitors,” which includes coverage of Amira’s AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.

Read more on News-Medical-Net